These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15919106)

  • 1. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
    So J; Wang FQ; Navari J; Schreher J; Fishman DA
    Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
    Dutta S; Wang FQ; Wu HS; Mukherjee TJ; Fishman DA
    Gynecol Oncol; 2011 Oct; 123(1):129-37. PubMed ID: 21782227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases.
    Wang FQ; So J; Reierstad S; Fishman DA
    Int J Cancer; 2006 Feb; 118(4):879-88. PubMed ID: 16152587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.
    Wang FQ; Barfield E; Dutta S; Pua T; Fishman DA
    Gynecol Oncol; 2009 Dec; 115(3):414-23. PubMed ID: 19765808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.
    So J; Navari J; Wang FQ; Fishman DA
    Gynecol Oncol; 2004 Nov; 95(2):314-22. PubMed ID: 15491751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
    Wang FQ; Smicun Y; Calluzzo N; Fishman DA
    Mol Cancer Res; 2006 Nov; 4(11):831-41. PubMed ID: 17114341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.
    Devine KM; Smicun Y; Hope JM; Fishman DA
    Gynecol Oncol; 2008 Aug; 110(2):237-45. PubMed ID: 18513786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.
    Wang FQ; Ariztia EV; Boyd LR; Horton FR; Smicun Y; Hetherington JA; Smith PJ; Fishman DA
    Gynecol Oncol; 2010 Apr; 117(1):88-95. PubMed ID: 20056268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
    Wang FQ; Fisher J; Fishman DA
    Gynecol Oncol; 2011 Feb; 120(2):247-55. PubMed ID: 21093894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner.
    Gil OD; Lee C; Ariztia EV; Wang FQ; Smith PJ; Hope JM; Fishman DA
    Gynecol Oncol; 2008 Feb; 108(2):361-9. PubMed ID: 18073130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
    Estrella VC; Eder AM; Liu S; Pustilnik TB; Tabassam FH; Claret FX; Gallick GE; Mills GB; Wiener JR
    Int J Oncol; 2007 Aug; 31(2):441-9. PubMed ID: 17611702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
    Jeong KJ; Park SY; Cho KH; Sohn JS; Lee J; Kim YK; Kang J; Park CG; Han JW; Lee HY
    Oncogene; 2012 Sep; 31(39):4279-89. PubMed ID: 22249252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
    Pustilnik TB; Estrella V; Wiener JR; Mao M; Eder A; Watt MA; Bast RC; Mills GB
    Clin Cancer Res; 1999 Nov; 5(11):3704-10. PubMed ID: 10589790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.
    Do TV; Symowicz JC; Berman DM; Liotta LA; Petricoin EF; Stack MS; Fishman DA
    Mol Cancer Res; 2007 Feb; 5(2):121-31. PubMed ID: 17314270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.
    Fishman DA; Liu Y; Ellerbroek SM; Stack MS
    Cancer Res; 2001 Apr; 61(7):3194-9. PubMed ID: 11306508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lysophosphatidic acid receptor-2 expression by RNA interference decreases lysophosphatidic acid-induced urokinase plasminogen activator activation, cell invasion, and migration in ovarian cancer SKOV-3 cells.
    Wang GL; Wen ZQ; Xu WP; Wang ZY; Du XL; Wang F
    Croat Med J; 2008 Apr; 49(2):175-81. PubMed ID: 18461672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
    Sengupta S; Kim KS; Berk MP; Oates R; Escobar P; Belinson J; Li W; Lindner DJ; Williams B; Xu Y
    Oncogene; 2007 May; 26(20):2894-901. PubMed ID: 17130843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
    Wang FQ; So J; Reierstad S; Fishman DA
    Int J Cancer; 2005 Mar; 114(1):19-31. PubMed ID: 15523695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.
    Rosanò L; Varmi M; Salani D; Di Castro V; Spinella F; Natali PG; Bagnato A
    Cancer Res; 2001 Nov; 61(22):8340-6. PubMed ID: 11719468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice.
    Li H; Wang D; Zhang H; Kirmani K; Zhao Z; Steinmetz R; Xu Y
    Mol Cancer Ther; 2009 Jun; 8(6):1692-701. PubMed ID: 19509252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.